NCT04997473Recruiting
Behavioral Weight Loss Intervention Utilizing Mobile Health Technology in Hematopoietic Stem Cell Transplant Patients
Source: ClinicalTrials.gov · Last updated 28 Jan 2026
Brief summary (registry, in English)
Pilot study enrolling obese post HSCT (hematopoietic stem cell transplantation) patients at the hematology/oncology clinic at the Mattel Children's Hospital, University of California, Los Angeles. Parameters include percent over the 95th percentile (%BMIp95), zBMI, fasting metabolic metrics, addictive eating habits, and motivation for change.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 23 Jul 2021
- Start date
- 15 Aug 2021
- Primary completion date
- 9 Jan 2027
- Lead sponsor
- University of California, Los Angeles
- Diseases
- Obesity
- NCT number
- NCT04997473
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 15 Aug 2021 to the primary completion date, 9 Jan 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who are \< 100 days post-transplant at initial consultation will not be eligible for the study, but may become eligible if they are \>100 days post-transplant at their next consultation that falls within the enrollment window.
Other illness
- No patients will be excluded for any specific underlying medical condition, but decisions will be made on a case by case basis if a patient's functioning is deemed to significantly interfere with intervention participation.
Age
- Patients who are ≤ 13 or ≥ 30 years old are not eligible for the study.
Other
- Patients whose BMI does not fall under the obese category will be excluded.
Who the study is looking for
- Patients ≥ 13 and ≤ 30 years old with a history of HSCT of any type, at least 100 days post-transplant at initial consultation of the study, will be eligible for the study.
- Both male and female patients will be eligible.
- Patients must classify as obese, represented as Body mass index \[BMI\] ≥85th percentile for age and gender.
- Patients must also be able to read English since the app intervention is only available in English form.
Age in the registry: 13 years to 30 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| UCLA Mattel Children's Hospital Coordinator of this site? Confirm its status | Los Angeles | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.